Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain
Impacto económico del uso de patiromer en enfermedad renal crónica o insuficiencia cardíaca para el tratamiento de la hiperpotasemia crónica en España
Patricia de Sequeraa, Ramón Boverb, Yoana Ivanova-Markovac,
Corresponding author
yoana.ivanova@weber.org.es

Corresponding author.
, Alexandra Ivanovac, Almudena González-Domínguezc, Marta Vallsd, Verónica Campose
a Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, Spain
b Servicio de Cardiología, Hospital Universitario Clínico San Carlos, Madrid, Spain
c Departamento de Farmacoeconomía, Weber, Madrid, Spain
d Market Access, CSL Vifor, Barcelona, Spain
e Patient Regional Access, CSL Vifor, Barcelona, Spain
Read
2450
Times
was read the article
703
Total PDF
1747
Total HTML
Share statistics
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 52 49 101
2024 October 63 63 126
2024 September 64 55 119
2024 August 67 79 146
2024 July 51 46 97
2024 June 54 55 109
2024 May 70 57 127
2024 April 100 51 151
2024 March 77 32 109
2024 February 79 50 129
2024 January 1070 166 1236

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?